BioSpace News Archive

PacBio today announced PanDNA, a versatile Nanobind DNA extraction kit.

Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V., announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. Nordic Pharma recently expanded its pharmaceutical expertise in the U.S. by acquiring Visant Medical, Inc., a leader in medical technology innovation in Dry Eye Disease.

Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (“Defence” or the “Company”), one of the leading Canadian biotechnology companies working in the field of immune-oncology is pleased to announce that it arranges a financing, and its common shares have been upgraded to OTCQB.

Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces that it received a transparency notification from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names in the table below.

AB Science SA (Euronext - FR0010557264 - AB) today announced that the European Patent Office has issued a Notice of Allowance for a patent relating to methods of treating severe systemic mastocytosis (i.e. a medical use patent) with its lead compound masitinib, based on findings from study AB06006 [1].

Epiphany Dermatology announced it has expanded its presence in the Atlanta, Georgia, market through its partnership with Dr. Corinne Smith and her team at North Pointe Dermatology.

Florida Cancer Specialists & Research Institute, LLC is pleased to announce the appointments of Joel Grossman, MD and Maen Hussein, MD to its Executive Board.

GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, announced its provisional financial calendar for 2024.

Brain Navi announced the completion of the 100th case utilizing its neurosurgical navigation robot NaoTrac.